DC PHARMA Trademark

Trademark Overview


On Friday, February 10, 2023, a trademark application was filed for DC PHARMA with the United States Patent and Trademark Office. The USPTO has given the DC PHARMA trademark a serial number of 79366207. The federal status of this trademark filing is REGISTERED as of Tuesday, June 25, 2024. This trademark is owned by YANTAI DONGCHENG BIOCHEMICALS CO., LTD.. The DC PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic radiopharmaceutical preparations; vitamin tablets; medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, oncological diseases, cardiovascular and cerebrovascular diseases, colds, cough, influenza, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; biochemical medicines for the treatment of cancer; liquid herbal supplements; medicinal drinks; capsules sold empty for pharmaceuticals; pharmaceutical preparations, namely, antivirals; radioactive substances for medical purposes; pharmaceutical preparations for treating chemical imbalances; mixed biological preparations for the prevention and treatment of infectious diseases; isotopes for medical purposes; diagnostic reagents for medicinal use; diagnostic preparations for medical purposes; drug delivery agents in the form of powders that provide con...
dc pharma

General Information


Serial Number79366207
Word MarkDC PHARMA
Filing DateFriday, February 10, 2023
Status700 - REGISTERED
Status DateTuesday, June 25, 2024
Registration Number7423994
Registration DateTuesday, June 25, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements


Description of MarkThe mark consists of four Chinese characters and stylized letters "DC PHARMA" to the right and a design of two semicircles of irregular shapes to the left.
NOT AVAILABLEThe non-Latin characters in the mark transliterate from left to right to "DONG", "CHENG", "YAO" and "YE". The four non-Latin characters may be translated into English as "East", "Honest", "Medicine" and "Industry". The whole combination conveys no special meaning.
Goods and ServicesDiagnostic radiopharmaceutical preparations; vitamin tablets; medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, oncological diseases, cardiovascular and cerebrovascular diseases, colds, cough, influenza, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; biochemical medicines for the treatment of cancer; liquid herbal supplements; medicinal drinks; capsules sold empty for pharmaceuticals; pharmaceutical preparations, namely, antivirals; radioactive substances for medical purposes; pharmaceutical preparations for treating chemical imbalances; mixed biological preparations for the prevention and treatment of infectious diseases; isotopes for medical purposes; diagnostic reagents for medicinal use; diagnostic preparations for medical purposes; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; injectable pharmaceuticals for treatment of anaphylactic reactions; medicines made of Chinese traditional medicinal herbs; dietary supplements
NOT AVAILABLE"PHARMA" and the non-Latin characters that transliterate to "YAO" and "YE,"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, April 2, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameYANTAI DONGCHENG BIOCHEMICALS CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameYANTAI DONGCHENG BIOCHEMICALS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameYANTAI DONGCHENG BIOCHEMICALS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Thursday, March 30, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 30, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Sunday, April 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 6, 2023APPLICATION FILING RECEIPT MAILED
Thursday, November 9, 2023ASSIGNED TO EXAMINER
Wednesday, February 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 22, 2023NON-FINAL ACTION WRITTEN
Thursday, November 23, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 28, 2023REFUSAL PROCESSED BY MPU
Tuesday, November 28, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 19, 2023REFUSAL PROCESSED BY IB
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 27, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 27, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 16, 2024NOTIFICATION PROCESSED BY IB
Friday, March 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 25, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 25, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, September 25, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB